Ocean Biomedical, Inc.

Aesther Healthcare Acquisition Corp. (Nasdaq: AEHA), sponsored by Aesther Healthcare Sponsor LLC, completed its SPAC initial public offering in 2021 targeting the healthcare and biopharmaceutical sector. The blank-check company filed an 8-K on June 2, 2022, in connection with its proposed business combination with Ocean Biomedical, Inc., a Providence, Rhode Island-based biopharmaceutical company focused on developing treatments across oncology, pulmonary disease, and infectious disease. The de-SPAC transaction, which ultimately closed in early 2023, brought Ocean Biomedical to the public markets under the AEHA ticker. Readers seeking full filing history, transaction timelines, and sponsor details for AEHA can sign up for complete data access at SpacDesk.